Evidence map›Paper›PMID 29844051›Full record

ArticleAntimicrobial agents and chemotherapy2018

Miltefosine Has a Postantifungal Effect and Induces Apoptosis in Cryptococcus Yeasts.

Cristina de Castro Spadari, Taissa Vila, Sonia Rozental, Kelly Ishida

Open access · bronzeAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 64 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Osh2 mediatesAntimicrobial agents and chemotherapy · 2025
    Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Study onMolecules (Basel, Switzerland) · 2024
    Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Miltefosine: A Repurposing Drug against Mucorales Pathogens.Journal of fungi (Basel, Switzerland) · 2023
    Article
  19. Article
  20. Newly Discovered Antimicrobial Peptide ScyampcinAntimicrobial agents and chemotherapy · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Cristina de Castro SpadariLaboratório de Quimioterapia Antifúngica, Departamento de Microbiologia, Instituto de Ciências Biomédicas, Universidade de São Paulo, São Paulo, SP, Brazil.ORCID 0000-0001-7486-5742
Taissa VilaDepartment of Oncology and Diagnostic Sciences, University of Maryland, Baltimore, Maryland, USA.ORCID 0000-0001-5600-4367
Sonia RozentalLaboratório de Biologia Celular de Fungos, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil.ORCID 0000-0002-3659-5945
Kelly IshidaLaboratório de Quimioterapia Antifúngica, Departamento de Microbiologia, Instituto de Ciências Biomédicas, Universidade de São Paulo, São Paulo, SP, Brazil ishidakelly@usp.br.ORCID 0000-0002-4602-0926
Universidade de São Paulo · BRUniversidade Federal do Rio de Janeiro · BRUniversity of Maryland, Baltimore · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Amphotericin BAntifungal AgentsApoptosisBiofilmsCell MembraneCell Membrane PermeabilityCryptococcosisCryptococcus gattiiCryptococcus neoformansDNA FragmentationErgosterolFungal CapsulesHumansMembrane Potential, MitochondrialMicrobial Sensitivity TestsOpportunistic InfectionsAmphotericin BAntifungal AgentsErgosterolmiltefosinePhosphorylcholineReactive Oxygen SpeciesapoptosisCryptococcusergosterolfungicidal effectmembrane permeabilitymiltefosinemitochondriapostantifungal effect

Identifiers

PMID29844051
PMCPMC6105859
OpenAlexW2980769487

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.